- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Draper Today
By the People, for the People
HealthEquity Upgraded to 'Outperform' by BMO Capital Markets
Analysts raise price target on the healthcare technology company's stock
Apr. 9, 2026 at 12:33pm
Got story updates? Submit your updates here. ›
The upgraded rating and price target for HealthEquity signal analysts' confidence in the company's ability to leverage its fintech infrastructure to drive continued growth.Draper TodayBMO Capital Markets has upgraded shares of HealthEquity (NASDAQ: HQY) from 'market perform' to 'outperform' and raised the price target from $85 to $105, representing a potential upside of 28.13% from the company's current trading price.
Why it matters
The upgrade and increased price target from BMO Capital Markets signals the analysts' confidence in HealthEquity's growth prospects and ability to outperform the broader market. As a leading administrator of consumer-directed healthcare accounts, HealthEquity's performance is closely watched by investors in the fintech and healthcare technology sectors.
The details
In their research note, BMO Capital Markets cited HealthEquity's strong market position and ability to capitalize on the growing demand for health savings accounts (HSAs) and related benefit solutions. The analysts believe the company is well-positioned to continue expanding its customer base and driving revenue growth.
- The research note and upgrade were issued on Thursday, April 9, 2026.
The players
HealthEquity
A leading administrator of consumer-directed health accounts and related benefit solutions in the United States, founded in 2002 and headquartered in Draper, Utah.
BMO Capital Markets
A global investment bank and financial services provider that provides research, trading, and investment banking services.
What’s next
Investors will be closely watching HealthEquity's upcoming financial results and guidance to see if the company is able to deliver on the increased expectations set by the BMO Capital Markets upgrade.
The takeaway
The BMO Capital Markets upgrade and price target increase reflect the analysts' belief that HealthEquity is well-positioned to capitalize on the growing demand for consumer-directed healthcare solutions, which could drive continued growth and outperformance for the company.
